You have 9 free searches left this month | for more free features.

Condition

Breast Neoplasms (1)

Prostate Cancer (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

early phase 1 (1)

phase 2 (1)

Sponsor

Boehringer Ingelheim (1)

University of Oxford (1)

Collaborator

Boehringer Ingelheim (1)

Prostate Cancer UK (1)

Intervention

xentuzumab (2)

everolimus (1)

exemestane (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

xentuzumab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Prostate Cancer Trial in Oxford (Xentuzumab)

Recruiting

Prostate Cancer

Xentuzumab

Oxford, United Kingdom

Churchill Hospital, Oxford University Hospitals

Mar 14, 2022

Breast Tumors Trial in Worldwide (Xentuzumab, Placebo, Everolimus)

Completed

Breast Neoplasms

Xentuzumab
+3 more

Chandler, Arizona
+53 more

Dec 13, 2022